Judy Olian, Director at Ares Management, holds 7.30K shares in United Therapeutics (Ticker: UTHR), holds 36.32K shares in Mattel (Ticker: MAT), holds 30.73K shares in Ares Management (Ticker: ARES). Most recently, Judy Olian Sold ― shares of United Therapeutics on May 06, 2024 for an estimated value of 2.59M.